19.07USD-9.62%Mkt Cap: 26.49M USDP/E: —Last update: 2026-06-01
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of th…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap26.49M USD
Enterprise Value-173.39M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-21.09M USD
Revenue/Share—
Last Price19.07 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS81728A1088
Valuation
P/E (Trailing)—
P/E (Forward)-5.32
PEG—
EV/EBITDA0.94
EV/Revenue—
P/S—
P/B1.43
EPS (TTM)-142.72
EPS (Forward)-3.97
52W Range
5.60043% of range36.76
52W High36.76 USD
52W Low5.600 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-113.41%
ROA-92.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.45M USD
CapEx (TTM)16.00K USD
FCF Margin—
FCF Yield-348.20%
Net Debt-201.75M USD
Net Debt/EBITDA1.09
Balance Sheet
Debt/Equity0.08
Current Ratio14.39
Quick Ratio14.29
Book Value/Sh14.74 USD
Cash/Share151.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 17, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)51.67 USD
Target Range50.00 USD – 55.00 USD
# Analysts3
Ownership
Shares Out.1.34M
Float811.87K
Insiders30.15%
Institutions159.90%
Short Interest
Short Ratio26.0d
Short % Float86.43%
Short % Out.60.77%
Shares Short815.54K
Short (prev mo.)855.82K
Technical
SMA 5026.70 (-28.6%)
SMA 20015.87 (+20.2%)
Beta-0.18
S&P 52W Chg27.70%
Avg Vol (30d)32.98K
Avg Vol (10d)34.00K
Technical Indicators
RSI (14)46.7
MACD-2.5643
MACD Signal-2.7032
MACD Hist.+0.1389
BB Upper27.84 USD
BB Middle20.90 USD
BB Lower13.96 USD
BB Width66.44%
ATR (14)2.619 USD
Vol Ratio (20d)1.76x